HOPE Act
Latest action · Apr 16, 2007 Referred to the House Committee on Energy and Commerce.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 29, 2007
- Passed SenateApr 11, 2007
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)
Hope Offered through Principled and Ethical Stem Cell Research Act or the HOPE Act - (Sec. 3) Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop techniques for the isolation, derivation, production, or testing of stem cells, including pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not they have an embryonic source), that may result in improved understanding of or treatments for diseases and other adverse health conditions, provided that such techniques do not involve: (1) the creation of a human embryo or embryos for research purposes; or (2) the destruction or discarding of, or risk of injury to, a human embryo of embryos other than those that are naturally dead.
Requires the Secretary to: (1) provide guidance concerning the next steps required for additional research; (2) prioritize research with the greatest potential for near-term clinical benefits; (3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research; and (4) require assurances from grant applicants, in the case of research involving stem cells from a naturally dead embryo, that no alteration of the timing, methods, or procedures used to create, maintain, or intervene in the development of a human embryo was made solely for the purpose of deriving the stem cells.
Sets forth reporting requirements.
Authorizes appropriations.
(Sec. 4) Directs the Secretary to enter into a contract with the Institute of Medicine to conduct a study to: (1) recommend an optimal structure for an amniotic and placental stem cell bank program; and (2) address pertinent issues to maximize the potential of such technology.
Recorded votes 1
Newest first. Open one to see how every member voted.
| Roll call | Question | Result | Date |
|---|---|---|---|
| Senate 128 | On Passage of the Bill S. 30 | Bill Passed70–28 | Apr 11, 2007 |
Cosponsors 6
Members who signed on, in the order they did. Signatures ran from Mar 29, 2007 to Apr 10, 2007; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-GA | Johnny Isakson | Original | Mar 29, 2007 |
| R-TX | John Cornyn | Apr 10, 2007 | |
| R-KY | Mitch McConnell | Apr 10, 2007 | |
| R-NC | Richard Burr | Apr 10, 2007 | |
| R-GA | Saxby Chambliss | Apr 10, 2007 | |
| R-OK | Tom Coburn | Apr 10, 2007 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Apr 16, 2007 |
Actions 8
Everything that happened, newest first.
- Apr 16, 2007Received in the House.
- Apr 16, 2007Referred to the House Committee on Energy and Commerce.
- Apr 12, 2007Message on Senate action sent to the House.
- Apr 11, 2007Considered by Senate. (consideration: CR S4319-4371, S4386-4391)
- Apr 11, 2007Passed/agreed to in Senate: Passed Senate, having acquired the 60 votes required under unanimous consent, without amendment by Yea-Nay Vote. 70 - 28. Record Vote Number: 128. (text as passed Senate: CR S4390-4391)
- Apr 10, 2007Measure laid before Senate by unanimous consent. (consideration: CR S4237-4294)
- Mar 29, 2007Introduced in Senate
- Mar 29, 2007Introduced in the Senate and read twice and ordered held at desk.
In the Congressional Record 6
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Printed hearings 2
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| Serial No. 110-58 | THE ECONOMIC EFFECTS OF THE RECENTLY INCREASED MINIMUM WAGE81 pages | Natural Resources Committee | Feb 22, 2008 |
| S. Hrg. 110-1033 | MOVING FORWARD AFTER HURRICANES KATRINA AND RITA188 pages | Environment and Public Works Committee | Feb 26, 2007 |
Titles 5
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to intensify research to derive human pluripotent stem cell lines.
- Short Titles as Introduced
- HOPE Act
- Hope Offered through Principled and Ethical Stem Cell Research Act
- Short Titles as Passed Senate
- HOPE Act
- Hope Offered through Principled and Ethical Stem Cell Research Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 3
Each version as it was printed, newest first.
- Apr 11, 2007Engrossed in Senate
- Mar 30, 2007Referred in House
- Mar 29, 2007Held at Desk Senate
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.